8-chloro-3,4-dihydro-2-isopropyl-3-thioxo-2H-1,4-benzoxazine-4-acetic acid | 112808-27-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 8-chloro-3,4-dihydro-2-isopropyl-3-thioxo-2H-1,4-benzoxazine-4-acetic acid
• 英文别名: 2-(8-Chloro-2-propan-2-yl-3-sulfanylidene-1,4-benzoxazin-4-yl)acetic acid
• CAS: 112808-27-2
• 化学式: C₁₃H₁₄ClNO₃S
• 分子量: 299.778
• InChiKey: IYHLHDKPQANVAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  81.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  8-chloro-3,4-dihydro-2-isopropyl-2H-1,4-benzoxazine-3(4H)-one 生成 8-chloro-3,4-dihydro-2-isopropyl-3-thioxo-2H-1,4-benzoxazine-4-acetic acid
  参考文献：
  名称：

  MEHGURO, KANDZI;IKEHDA, MAMORU;YAMAMOTO, YUDZIRO

  摘要：

  DOI：

文献信息

• Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: Synthesis and biological activity.
  作者：Hiroyuki TAWADA、Yasuo SUGIYAMA、Hitoshi IKEDA、Yujiro YAMAMOTO、Kanji MEGURO

  DOI：10.1248/cpb.38.1238

  日期：——

  N-Acetic acid derivatives (I) of 2-substituted 1, 4-benzoxazines and benzothiazines were designed and synthesized for evaluation as new aldose reductase inhibitors. In general, 3-thioxo derivatives were more potent inhibitors of aldose reductase from human placenta in vitro than the corresponding 3-oxo derivatives. While many compounds (I) were not very effective in inhibiting sorbitol accumulation in the rat sciatic nerve in vivo, the 3-thioxo compounds bearing an isopropyl group at the 2-position showed highly potent activity in the in vivo assay. Compound 46 (AD-5467) was selected from this series as a candidate for further development.

  N-乙酸衍生物（I）的2-取代基1,4-苯并恶嗪和苯并噻嗪被设计合成，以评估其作为新型醛糖还原酶抑制剂的潜力。一般而言，3-硫代羰基衍生物在体外对人胎盘醛糖还原酶的抑制活性比相应的3-氧代衍生物更强。虽然许多化合物（I）在体内对大鼠坐骨神经山梨醇积累的抑制作用并不十分有效，但在体内试验中，2-位带有异丙基的3-硫代羰基化合物显示出极强的活性。从这一系列中选出化合物46（AD-5467）作为进一步开发的候选药物。
• Thiolactam-N-acetic acid derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0243018A1

  公开（公告）日：1987-10-28

  Compounds of the general formula: (wherein, R' and R2 are, the same or different, hydrogen, a halogen, a lower alkyl, a cycloalkyl, a lower alkoxy, a phenylalkyloxy, or trifluoromethyl; R3 is hydrogen or methyl; R' is carboxyl or an esterified carboxyl; and X is oxygen or sulfur), or a salt thereof, are novel compounds, possess aldose reductase inhibitory and platelet aggregation innibitory activities, and of use as drugs for prevention and treatment of diabetic complications such as diabetic cataract, retinophathy, nephropathy, and neuropathy.

  通式如下的化合物 (其中，R'和 R2 相同或不同，为氢、卤素、低级烷基、环烷基、低级烷氧基、苯基烷氧基或三氟甲基；R3 为氢或甲基；R'为羧基或酯化羧基；X为氧或硫）或其盐是新型化合物，具有抑制醛糖还原酶和抑制血小板聚集的活性，可用作预防和治疗糖尿病并发症如糖尿病性白内障、视网膜病变、肾病和神经病变的药物。
• TAWADA, HIROYUKI;SUGIYAMA, YASUO;IKEDA, HITOSHI;YAMAMOTO, YUJIRO;MEGURO, +, CHEM. AND PHARM. BULL., 38,(1990) N, C. 1238-1245
  作者：TAWADA, HIROYUKI、SUGIYAMA, YASUO、IKEDA, HITOSHI、YAMAMOTO, YUJIRO、MEGURO, +

  DOI：——

  日期：——
• US4771050A
  申请人：——

  公开号：US4771050A

  公开（公告）日：1988-09-13